Kimberly Gentile
Senior Vice President of Clinical OperationsMs. Kimberly Gentile, also known as Kim, serves as Senior Vice President of Clinical Operations at Biohaven Ltd. She served as Senior Vice President of Clinical Operations at Biohaven Pharmaceutical Holding Company Ltd. since January 2017 until October 03, 2022 and had been its Director until October 03, 2022 and served as its Vice President of Clinical Operations since February 2014 until 2019. Before joining to Biohaven, Ms. Gentile served as Associate Director and Project Manager of Global Clinical Operations at Bristol-Myers Squibb Company from 2000 to February 2014. Prior to this, she was a senior clinical trial manager at SCIREX Corporation from 1996 to June 2000. Ms. Gentile received her B.S. in Psychology from Salem State University.
Positions
- Company NameBiohaven Ltd.Stock CodeBHVNPositionSenior Vice President of Clinical OperationsColleagues
- VCVladimir CoricChairman & CEO
- MBMatthew ButenChief Financial Officer
- BDBruce D. CarChief Innovation Officer
- DYDeb YoungSenior Director of Regulatory Affairs & Operations
- DGDouglas GrayCorporate Secretary & Director
- MTMichael Thomas HeffernanLead Independent Director
- GHGregory H. BaileyIndependent Director
- JWJohn Winston ChildsIndependent Director
